Boehringer exercises option for Eureka's TCR-mimicking antibodies

Boehringer Ingelheim GmbH (Ingelheim, Germany) exercised a 2015 option

Read the full 92 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE